Balentine LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,412
Closed -$529K 188
2024
Q3
$529K Buy
8,412
+3,057
+57% +$192K 0.02% 96
2024
Q2
$316K Sell
5,355
-4,954
-48% -$293K 0.01% 97
2024
Q1
$822K Buy
10,309
+1,879
+22% +$150K 0.02% 213
2023
Q4
$666K Buy
8,430
+572
+7% +$45.2K 0.02% 237
2023
Q3
$549K Buy
7,858
+447
+6% +$31.2K 0.02% 249
2023
Q2
$512K Sell
7,411
-3,545
-32% -$245K 0.02% 263
2023
Q1
$814K Sell
10,956
-16,654
-60% -$1.24M 0.03% 221
2022
Q4
$2.57M Sell
27,610
-8,687
-24% -$810K 0.09% 82
2022
Q3
$3.46M Sell
36,297
-15,645
-30% -$1.49M 0.13% 48
2022
Q2
$4.81M Buy
51,942
+19,198
+59% +$1.78M 0.18% 43
2022
Q1
$3.31M Buy
32,744
+19,343
+144% +$1.96M 0.11% 45
2021
Q4
$1.38M Buy
13,401
+2,481
+23% +$256K 0.05% 66
2021
Q3
$927K Buy
10,920
+5,476
+101% +$465K 0.04% 69
2021
Q2
$454K Buy
5,444
+2,561
+89% +$214K 0.02% 90
2021
Q1
$217K Buy
+2,883
New +$217K 0.01% 133
2020
Q3
Sell
-1,575
Closed -$102K 315
2020
Q2
$102K Buy
1,575
+780
+98% +$50.5K 0.01% 150
2020
Q1
$47K Sell
795
-324
-29% -$19.2K ﹤0.01% 186
2019
Q4
$83K Sell
1,119
-2,288
-67% -$170K ﹤0.01% 134
2019
Q3
$215K Buy
3,407
+3,068
+905% +$194K 0.01% 62
2019
Q2
$18K Sell
339
-2,801
-89% -$149K ﹤0.01% 222
2019
Q1
$169K Sell
3,140
-99
-3% -$5.33K 0.01% 63
2018
Q4
$212K Buy
3,239
+3,059
+1,699% +$200K 0.02% 60
2018
Q3
$14K Buy
+180
New +$14K ﹤0.01% 157
2018
Q2
Sell
-65
Closed -$4K 121
2018
Q1
$4K Sell
65
-2,720
-98% -$167K ﹤0.01% 55
2017
Q4
$202K Sell
2,785
-717
-20% -$52K 0.02% 121
2017
Q3
$285K Buy
3,502
+889
+34% +$72.3K 0.02% 87
2017
Q2
$210K Hold
2,613
0.02% 104
2017
Q1
$205K Buy
2,613
+781
+43% +$61.3K 0.02% 102
2016
Q4
$145K Buy
1,832
+1,164
+174% +$92.1K 0.02% 121
2016
Q3
$59K Sell
668
-22
-3% -$1.94K 0.01% 158
2016
Q2
$66K Buy
690
+122
+21% +$11.7K 0.01% 136
2016
Q1
$59K Hold
568
0.02% 100
2015
Q4
$56K Sell
568
-560
-50% -$55.2K 0.01% 149
2015
Q3
$109K Buy
1,128
+220
+24% +$21.3K 0.02% 92
2015
Q2
$95K Sell
908
-1,483
-62% -$155K 0.02% 96
2015
Q1
$247K Buy
+2,391
New +$247K 0.05% 38